Skip to content

Music therapy for chemotherapy induced nausea and vomiting

Prevention and treatment of chemotherapy induced nausea and vomiting using music therapy interventions for people undergoing medium or high risk emetogenic chemotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622001495718
Enrollment
10
Registered
2022-11-29
Start date
2025-02-25
Completion date
2026-02-01
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Chemotherapy induced nausea and vomiting is a well-recognised problem for patients undergoing cancer treatment. While significant progress has been made over the last few years, nausea remains a debilitating issue for some people and therefore newer treatment interventions are required. Among the non-drug interventions, music therapy intervention appears promising based on its previously demonstrated health benefits. Therefore, the aim of the study is to evaluate the feasibility and acceptability of a novel music therapy intervention for the prevention and treatment of chemotherapy induced nausea and vomiting. Who is it for? You may be eligible to join this study if you are aged 18 years or older, and are planned to undergo systemic chemotherapy for your cancer that is known to be associated with nausea and vomiting. Study details All participants will be provided with a music listening device with preloaded music that was recorded using music therapy principles designed to promote relaxation. The device will be given to participants at the beginning of their first and second chemotherapy cycles. Participants will be asked to listen to a minimum of 5-15 minutes of music through using the device during each day chemotherapy cycles. Before and after the first and second cycle, the participant will complete questionnaires using the device regarding chemotherapy induced symptoms, symptoms of nausea and vomiting, and sleep quality. It is hoped that this study will show that music therapy is feasible, acceptable, and effective for the prevention and treatment of chemotherapy induced nausea and vomiting in cancer patients undergoing chemotherapy.

Interventions

1. Brief Name: Music therapy for chemotherapy induced nausea and vomiting 2. Why: There is currently insufficient treatment for chemotherapy induced nausea and vomiting. Nausea is poorly controlled with current pharmacological therapies. Among the non-pharmacological interventions, music therapy intervention appears promising based on its previously demonstrated health benefits. 3. What: Participants will be provided with an iPod touch and headphones. The iPod will have an application where pa

1. Brief Name: Music therapy for chemotherapy induced nausea and vomiting 2. Why: There is currently insufficient treatment for chemotherapy induced nausea and vomiting. Nausea is poorly controlled with current pharmacological therapies. Among the non-pharmacological interventions, music therapy intervention appears promising based on its previously demonstrated health benefits. 3. What: Participants will be provided with an iPod touch and headphones. The iPod will have an application where participants can listen to 5 different pieces of music written and recorded specifically for this project. The application will incorporate the following questionnaires for assessment - Functional Living Index Emesis (FLIE 5D), Edmonton Symptom Assessment System (ESAS) and Pittsburgh Sleep Quality Index (PSQI). 4. Procedures: Participants will be asked to engage with the music therapy intervention on days 1-6 of both their first and second treatment cycles, with the addition of completing surveys and questionnaires the day after each cycle (Day 7), totalling 14 days of engagement with the study. On the first day of the first cycle of treatment, participants will be met by a researcher who will provide consultation and an information sheet before obtaining signed consent, this will take approximately 30mins On each of the 12 days of the music therapy intervention, participants will be asked to listen to a minimum of 5-15 minutes of music through the application. There is no maximum time that participants can listen to the music, however, the application will not allow access to music outside of the treatment cycles. Music listening will be unsupervised and will be available for participants to engage with at the infusion suite or any other place of their choosing. All interaction of music listening will be tracked through the application and made available as data for the researchers but not participants. Immediately prior to each cycle, participants will be prompted and supported by the researcher to use the application to complete the FLIE 5D, ESAS and PSQI, these will take approximately 10 minutes to complete on each occasion. On the day following the end of each cycle, the application will prompt the participant through a notification to again complete the FLIE 5D, ESAS and PSQI, again these will take approximately 10 minutes to complete on each occasion. Additionally, on the first day of their treatment, prior to beginning the music therapy intervention, participants will be asked to complete a one-time questionnaire about the music on the application. 5. Who Provided: The research coordinator will provide and train the participants for using the device and filling questionnaires. 6. The project is being conducted through the cancer clinic of a hospital. Recruitment and initial consolation will be conducted with the participant at the cancer clinic, participants will engage with the intervention at the cancer clinic and will also have the option to participate with the intervention outside of the clinic.

Sponsors

Flinders Foundation
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Participants who are planned to undergo systemic therapy for their cancer with regimen that are medium emetogenic chemotherapy (MEC) or highly emetogenic chemotherapy. 2. Capable of giving signed informed consent. 3. Able to understand English.

Exclusion criteria

1. Previously have had chemotherapy 2. Planned for or prior cranial radiotherapy 3. Established cognitive impairment 4. Significant baseline nausea and vomiting from cancer or other diseases such as bowel or gastric outlet obstruction 5. Pregnant at study entry 6. Known significant hearing impairment not corrected by hearing aids

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026